Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial - Authors' reply.
Saved in:
| Title: | Cadonilimab in advanced cervical cancer: the COMPASSION-16 trial - Authors' reply. |
|---|---|
| Authors: | Liu T; Akeso Biopharma, Zhongshan, China., Lu D; Akeso Biopharma, Zhongshan, China., Wu X; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China. Electronic address: wu.xh@fudan.edu.cn. |
| Source: | Lancet (London, England) [Lancet] 2025 Aug 02; Vol. 406 (10502), pp. 446. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
